SCOPUS 정보 검색 플랫폼

Volumn 19, Issue 3, 2001, Pages 255-260

A phase II trial of weekly intravenous ranpirnase (Onconase®), a novel ribonuclease in patients with metastatic kidney cancer

(5) Vogelzang, Nicholas J a Aklilu, Mebea b Stadler, Walter M b,c Dumas, Mary C c Mikulski, Stanislaw M c

a University of Chicago (United States)

b UNIVERSITY OF CHICAGO (United States)

c Alfacell Corporation (United States)

Author keywords

Kidney cancer; Onconase ; Phase II; Ribonuclease

Indexed keywords

RANPIRNASE; RIBONUCLEASE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DRUG ACTIVITY; EDEMA; FEMALE; HUMAN; KIDNEY CARCINOMA; KIDNEY METASTASIS; MALE; MESOTHELIOMA; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEINURIA; SOLID TUMOR; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; RIBONUCLEASES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0034857891 PISSN: 01676997 EISSN: None Source Type: Journal
DOI: 10.1023/A:1010633004157 Document Type: Article

Times cited : (25)

References (34)

1
- 0032556354
- Kidney cancer
- (1998) The Lancet , vol.352 , pp. 1691-1696
- Vogelzang, N.J.¹ Stadler, W.M.²

2
- 0030931682
- Natural history and therapy of metastatic renal cell carcinoma: The role of interleukin-2
- (1997) Cancer , vol.80 , Issue.7 , pp. 1198-1220
- Bukowski, R.M.¹

3
- 0027462554
- Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinoma
- (1993) J Clin Oncol , vol.11 , pp. 661-670
- Atkins, M.B.¹ Sparano, J.² Fisher, R.I.³ Weiss, G.R.⁴ Margolin, K.A.⁵ Fink, K.I.⁶ Rubinstein, L.⁷ Louie, A.⁸ Mier, J.W.⁹ Gucalp, R.¹⁰

4
- 0028809089
- Multi-institutional home-therapy trial of recombinant human interleukin-2 and interferon alfa-2 in progressive metastatic renal cell carcinoma
- (1995) J Clin Oncol , vol.13 , Issue.2 , pp. 497-501
- Atzpodien, J.¹ Lopez Hanninen, E.² Kirchner, H.³ Bodenstein, H.⁴ Pfreundschuh, M.⁵ Rebmann, U.⁶ Metzner, B.⁷ Illiger, H.J.⁸ Jakse, G.⁹ Niesel, T.¹⁰

5
- 0031424976
- Interleukin-2-based therapy for metastatic renal cell cancer: The Cytokine Working Group experience, 1989-1997
- (1997) Cancer J Sci Am , vol.3 , Issue.SUPPL. 1
- Dutcher, J.P.¹ Atkins, M.² Fisher, R.³ Weiss, G.⁴ Margolin, K.⁵ Aronson, F.⁶ Sosman, J.⁷ Lotze, M.⁸ Gordon, M.⁹ Logan, T.¹⁰ Mier, J.¹¹

6
- 0027199879
- Subcutaneous interleukin-2 plus interferon alfa-2a in metastatic renal cancer: An outpatient multicenter trial
- (1993) J Clin Oncol , vol.11 , Issue.9 , pp. 1809-1816
- Vogelzang, N.J.¹ Lipton, A.² Figlin, R.A.³

7
- 0031804712
- Multi-center phase II trial of interleukin-2, interferon-α, and 13-cis-retinoic acid in patients with metastatic renal cell carcinoma
- (1998) J Clin Oncol , vol.16 , Issue.5 , pp. 1820-1825
- Stadler, W.M.¹ Kuzel, T.² Dumas, M.³ Vogelzang, N.J.⁴

8
- 0029165480
- Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: Antitumor activity in a phase II trial and interactions in vitro
- (1995) J Clin Oncol , vol.13 , Issue.8 , pp. 1950-1957
- Motzer, R.J.¹ Schwartz, L.² Law, T.M.³ Murphy, B.A.⁴ Hoffman, A.D.⁵ Albino, A.P.⁶ Vlamis, V.⁷ Nanus, D.M.⁸

9
- 2442737061
- Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer
- (1999) J Clin Oncol , vol.17 , Issue.9 , pp. 2859-2867
- Pyrhonen, S.¹ Salminen, E.² Ruutu, M.³ Lehtonen, T.⁴ Nurmi, M.⁵ Tammela, T.⁶ Juusela, H.⁷ Rintala, E.⁸ Hietanen, P.⁹ Kellokumpu-Lehtinen, P.L.¹⁰

10
- 0033514050
- Interferon-α and survival in metastatic renal carcinoma: Early results of a randomized controlled trial
- (1999) Lancet , vol.353 , pp. 14-17

11
- 7144227930
- Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma
- (1998) New Engl J Med , vol.338 , Issue.18 , pp. 1272-1278
- Negrier, S.¹ Escudier, B.² Lasset, C.³ Douillard, J.-Y.⁴ Savary, J.⁵ Chevreau, C.⁶ Ravaud, A.⁷ Mercatello, A.⁸ Peny, J.⁹ Mousseau, M.¹⁰ Philip, T.¹¹ Tursz, T.¹²

12
- 0032876256
- Diagnosis and treatment of leptomeningeal metastases in a patient with renal carcinoma responding to 5FU and Gemcitabine
- (1999) J Urol , vol.162 , Issue.1 , pp. 155-156
- Tippin, D.B.¹ Reeves, W.² Vogelzang, N.J.³

13
- 4243444285
- Gemcitabine (GEM) and 5-fluorouracil (5FU) in metastatic renal carcinoma (RC): A University of Chicago phase II consoritum study
- (1999) Proc Amer Soc Clin Oncol , vol.18
- Stadler, W.M.¹ Dumas, M.² Flickinger, S.³ Wade, J.⁴ Vokes, E.E.⁵ Vogelzang, N.J.⁶

14
- 0003854717
- A phase II trial of weekly intravenous gemcitabine with continuous infusion 5-fluorouracil (5FU) in patients with metastatic renal cell cancer
- in press
- (2001) J Clin Onc
- Rini, B.I.¹ Vogelzang, N.J.² Dumas, M.C.³ Wade, J.L.⁴ Taber, D.A.⁵ Stadler, W.M.⁶

15
- 15444354991
- Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer
- (1998) Clin Canc Res , vol.4 , pp. 929-934
- Vogelzang, N.J.¹ Mani, S.² Schilsky, R.L.³ Ansari, R.H.⁴ Taber, D.⁵ Rhinehart, S.N.⁶ Garcia, J.C.⁷ Meyer, S.C.⁸ Mick, R.⁹ Brockstein, B.E.¹⁰ Stadler, W.M.¹¹ Ratain, M.J.¹² Vokes, E.E.¹³

16
- 0000378189
- CI-980 in renal cell and non-small cell lung cancer: Multi-institutional trials from the University of Chicago phase II consortium
- (1998) Cancer Therapeutics , vol.1 , Issue.5 , pp. 318-320
- Stadler, W.M.¹ Vogelzang, N.J.² Hoffman, P.³ Arrietta, R.⁴ Masters, G.⁵ Fishkin, P.⁶ Gibbons, J.⁷ Lad, T.E.⁸ Vokes, E.⁹

17
- 0032767386
- Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma
- (1999) J Clin Oncol , vol.17 , Issue.8 , pp. 2541-2545
- Stadler, W.M.¹ Kuzel, T.² Shapiro, C.³ Sosman, J.⁴ Clark, J.⁵ Vogelzang, N.J.⁶

18
- 0034653889
- Granulocyte-macrophage-colony stimulating factor in combination immunotherapy for patients with metastatic renal cell carcinoma: Results of two phase II clinical trials
- (2000) Cancer , vol.88 , Issue.6 , pp. 1317-1324
- Ryan, C.W.¹ Vogelzang, N.J.² Dumas, M.C.³ Kuzel, T.⁴ Stadler, W.M.⁵

19
- 0032697619
- Phase I study of direct intralesional gene transfer of HLA-B7 into metastatic renal carcinoma lesions
- (1999) Clin Canc Res , vol.5 , pp. 2766-2772
- Rini, B.I.¹ Selk, L.M.² Vogelzang, N.J.³

20
- 84990553409
- Cytostatic and cytotoxic effects of Pannon (P-30 Protein) a novel anti-cancer agent
- (1988) Cell Tissue Kinet , vol.21 , pp. 169-182
- Darzynkiewicz, Z.¹ Carter, S.P.² Mikulski, S.M.³ Ardelt, W.J.⁴ Shogen, K.⁵

21
- 0025020007
- Striking increase of survival of mice bearing M109 Madison carcinoma treated with a novel protein from amphibian embryos
- (1990) J Natl Cancer Inst , vol.82 , pp. 151-153
- Mikulski, S.M.¹ Ardelt, W.² Shogen, K.³ Bernstein, E.H.⁴ Menduke, H.⁵

22
- 0025960523
- Amino acid sequence of an anti-tumor protein from Rana pipiens oocytes and early embryos. Homology to pancreatic ribonucleases
- (1991) J Biol Chem , vol.266 , pp. 245-251
- Ardelt, W.¹ Mikulski, S.M.² Shogen, K.³

23
- 0026670313
- Comparative molecular modeling and crystallization of P-30 Protein: A novel anti-tumor protein of Rana pipiens oocytes and early embryos
- (1992) Prot Struct Funct Gen , vol.14 , pp. 392-400
- Mosimann, S.C.¹ Johns, K.L.² Ardelt, W.³ Mikulski, S.M.⁴ Shogen, K.⁵ James, M.N.⁶

24
- 0028266432
- Refined 1.7 X-ray crystallographic structure of P-30 protein, an amphibian ribonuclease with anti-tumor activity
- (1994) J Mol Biol , vol.236 , pp. 1141-1153
- Mosimann, S.C.¹ Ardelt, W.² James, M.N.G.³

25
- 0025025564
- Tamoxifen and trifluoroperazine (Stelazine) potentiate cytostatic/cytotoxic effects of P-30 Protein, a novel protein possessing anti-tumor activity
- (1990) Cell Tissue Kinet , vol.23 , pp. 237-246
- Mikulski, S.M.¹ Viera, A.² Ardelt, W.³ Menduke, H.⁴ Shogen, K.⁵

26
- 15844415446
- Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with Onconase®, an antitumor ribonuclease
- (1996) J Natl Cancer Inst , vol.88 , Issue.11 , pp. 747-753
- Rybak, S.M.¹ Pearson, J.W.² Fogler, W.E.³ Volker, K.⁴ Spence, S.E.⁵ Newton, D.L.⁶ Mikulski, S.M.⁷ Ardelt, W.⁸ Riggs, C.W.⁹ Kung, H.F.¹⁰ Longo, D.L.¹¹

27
- 0034072727
- Molecular determinants of apoptosis induced by the cytotoxic ribonuclease onconase: Evidence for cytotoxic mechanisms different from inhibition of protein synthesis
- (2000) Cancer Res , vol.60 , pp. 1983-1994
- Iordanov, M.S.¹ Ryabinina, O.P.² Wong, J.³ Dinh, T.-H.⁴ Newton, D.L.⁵ Rybak, S.M.⁶ Magun, B.E.⁷

28
- 0003803364
- ALFACELL Corporation, Bloomfield, NJ
- (1999) Onconase® Investigator's Brochure

29
- 0027437455
- Phase I human clinical trial of Onconase® (P-30 Protein) administered intravenously on a weekly schedule in cancer patients with solid tumors
- (1993) Int J Oncol , vol.3 , pp. 57-64
- Mikulski, S.M.¹ Grossman, A.M.² Carter, P.W.³

30
- 0028952578
- Relationship between response rate and median survival in patients with advanced non-small cell lung cancer: Comparison on Onconase® with other anticancer agents
- (1995) Int J Onc , vol.6 , pp. 889-897
- Mikulski, S.M.¹ Chun, H.G.² Mittelman, A.³ Panella, T.⁴ Puccio, C.A.⁵ Shogen, K.⁶ Costanzi, J.J.⁷

31
- 4244131428
- A new anti-cancer Rnase (Onconase®): Preliminary results in patients with breast cancer
- Paris, France, July 3
- (1996) st meeting of the International Association for Breast Cancer Research
- Mittelman, A.¹ Puccio, C.² Chun, H.³ Costanzi, J.⁴ Panella, T.⁵ Coombe, N.⁶ Shogen, K.⁷ Mikulski, S.⁸

32
- 0006901107
- Phase II trial of Onconase® in patients (PTS) with advanced malignant mesothelioma (MM): Analysis of survival
- (1999) Proc Amer Soc Clin Oncol , vol.18
- Taub, R.N.¹ Keohan, M.L.² Vogelzang, N.J.³ Costanzi, J.⁴ Chun, H.⁵ Mittelman, A.⁶ Panella, T.⁷ McCachren, S.⁸ Puccio, C.⁹ Shogen, K.¹⁰ Fine, R.¹¹ Mikulski, S.M.¹²

33
- 4243444320
- Phase 11 clinical trial of weekly intravenous Onconase® (ONC) in patients (PTS) with metastatic renal cell carcinoma (RCC)
- (1998) Proc Amer Soc Clin Oncol , vol.17
- Dumas, M.C.¹ Stadler, W.² Mikulski, S.³ Vogelzang, N.J.⁴

34
- 0032772880
- Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma
- (1999) J Clin Oncol , vol.17 , Issue.8 , pp. 2530-2540
- Motzer, R.J.¹ Mazumdar, M.² Bacik, J.³ Berg, W.⁴ Amsterdam, A.⁵ Ferrara, J.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.